Skip to main content
. 2019 Dec 19;7:212. doi: 10.1186/s40478-019-0864-6

Table 1.

qPCR validation for immunoregulatory/neuroprotective genes

Gene qPCR validation
fold change (p-value versus control)
Microarray
fold change
Primer sequence
FGF2 F2 V2 FGF2 F2 V2
Cd93 240.2 ± 101.2 (***) 44.9 ± 9.1 (***) 74.1 23.8 CATCTCACTCTTGCTGGCTCT TCTCCTCTTTCTTGGCTTTCC
Il11 48.4 ± 19.8 (***) 14.9 ± 3.7 (**) 47.5 6.3 CTCCCCTCGAGTGTCTTCAG CCATCAGCTGGGAATTTGTC
Hb-egf 22.2 ± 12.0 (***) 7.1 ± 2.5 (**) 11.9 4.9 TTTCTCCTCCAAGCCACAAG TTCCTCTTCTTTTTCCCGTTC
Lif 13.6 ± 4.6 (***) 3.8 ± 1.7 (*) 19.4 4.0 CCTTCCCATCACCCCTGT CGTTGAGTTGAGCCAGTTGA
Cxcl1 12.5 ± 4.1 (***) 8.4 ± 1.8 (***) 4.0 5.6 AACCGAAGTCATAGCCACACTC CACCCTTTAGCATCTTTTGGAC
Timp1 6.2 ± 0.9 (**) 5.8 ± 1.8 (**) 2.8 2.3 CTGGTTCCCTGGCATAATCT ATCGCTCTGGTAGCCCTTCT
Mmp13 28.6 ± 14.0 (***) 2.2 ± 1.8 (ns) 28.1 1.2 CTGCGGTTCACTTTGAGGA GAGGCGGGGATAGTCTTTGT
Mmp3 8.1 ± 3.5 (*) 0.4 ± 1.2 (ns) 6.8 −1.0 CCCGTTTCCATCTCTCTCAA GACATCAGGGGATTCTGTGG

Shown are mean +/− SEM of at least 5 independent experiments; p-values for ΔCt of Control vs FGF2 or F2 V2 respectively (one-way ANOVA, Holm-Sidak post-test); * p < 0.05, ** p < 0.01, *** p < 0.001, ns - not significant